Glycopyrrolate

Product NDC: 63304-210
11-digit product format: 633040210
Labeler code: 63304
Product ID: 63304-210_ab2722ce-c08e-4cdd-a25e-756272ea463f
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Glycopyrrolate
Dosage form: TABLET
Route: ORAL
Labeler: Ranbaxy Pharmaceuticals Inc.
Application: ANDA040844
Marketing category: ANDA
Marketing start: 2009-08-18
Marketing end: 0000-00-00
Substance: GLYCOPYRROLATE
Active strength: 1 mg/1
Pharmacologic classes: Anticholinergic [EPC],Cholinergic Antagonists [MoA]
NDC exclude flag: No
Listing certified through: 2019-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 5 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	63304-210		I	Inactivated by FDA	2026-10-05
excluded package	package	63304-210	63304-210-01	I	Inactivated by FDA	2026-10-05
excluded package	package	63304-210	63304-210-10	I	Inactivated by FDA	2026-10-05
excluded package	package	63304-210	63304-210-30	I	Inactivated by FDA	2026-10-05
excluded package	package	63304-210	63304-210-69	I	Inactivated by FDA	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 105 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-210-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-210-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-210-69	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	63304-210-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-210-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-210-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-210-69	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	63304-210-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-210-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-210-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-210-69	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	63304-210-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-210-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-210-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-210-69	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	63304-210-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-210-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-210-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-210-69	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	63304-210-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-210-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-210-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-210-69	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	63304-210-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-210-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-210-10	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-210-69	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	63304-210-01	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-210-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-210-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-210-69	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	63304-210-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-210-30	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-210-10	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-210-69	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	63304-210-01	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-210-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-210-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-210-69	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	63304-210-01	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-210-30	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-210-10	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-210-69	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	63304-210-01	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-210-30	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-210-10	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-210-69	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	63304-210-01	`557ba5c1ecfa…`	`9c80585c8c6e…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040844-001	GLYCOPYRROLATE	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA		2009-08-18
A040844-002	GLYCOPYRROLATE	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA		2009-08-18

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A040844-001	AA
A040844-002	AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040844-001	GLYCOPYRROLATE	1MG	TABLET / ORAL	AA	2009-08-18	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A040844-002	GLYCOPYRROLATE	2MG	TABLET / ORAL	AA	2009-08-18	`74a2ff9319b5…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 3 · 86 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	A040844-001	AA	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	A040844-002	AA	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	A040844-001	AA	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	A040844-002	AA	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A040844-001	AA	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A040844-002	AA	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040844-001	AA	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040844-002	AA	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040844-001	AA	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A040844-002	AA	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040844-001	AA	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040844-002	AA	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040844-001	AA	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040844-002	AA	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040844-001	AA	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040844-002	AA	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040844-001	AA	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040844-002	AA	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040844-001	AA	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040844-002	AA	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040844-001	AA	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040844-002	AA	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040844-001	AA	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A040844-002	AA	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040844-001	AA	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040844-002	AA	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040844-001	AA	1	`301d65b070ca…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040844-002	AA	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040844-001	AA	1	`1e350fbaab3a…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040844-002	AA	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040844-001	AA	1	`8072bd15b7f6…`
2024-05-31 18:47 UTC	2024-05	A040844-002	AA	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040844-001	AA	1	`5c6f7cd8ea54…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040844-002	AA	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040844-001	AA	1	`5d02ea3f76ae…`
2022-04-08 23:34 UTC	2022-04	A040844-002	AA	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040844-001	AA	1	`4b0b4de00fa7…`
2022-04-04 05:41 UTC	2022-04	A040844-002	AA	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040844-001	AA	1	`74a2ff9319b5…`
2019-12-13 00:20 UTC	2019-12	A040844-002	AA	1	`74a2ff9319b5…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
138c3de2-4b03-4255-92b5-f022482d81bc	Product name	4	20260113
4dc252b1-bb5f-8bb6-4fa8-f3a45efd810e	Product name	5	20250304
f58f10d3-5fa9-4c2e-9a6e-77029e9ed80b	Product name	1	20231002
76dcac30-469f-4f92-9c55-70950d209446	Product name	1	20230809
132196a6-5117-4b6e-a9dd-27f2793580c6	Product name	1	20230112
ac1f888b-a1db-4d2e-abbc-973f21c2ce1b	Product name	1	20220720
d84dd569-7bf0-1410-25eb-017ef37dd406	Product name	9	20210902
7d8c8d5a-f174-4e6b-97b1-6fd615c5df9a	Product name	1	20210204
58b12de9-b891-41c7-9be6-ff47de5ec28b	Product name	1	20180828
9aff7b10-8e47-4b10-9a92-803440a37ce2	Product name	1	20180206
ce066c73-ca6f-49fc-83d4-d3cf6728e8a1	Product name	1	20160616
fb29b8a9-c2d0-42bb-aea8-9bc2a87db75a	Product name	1	20151113
ab7ba50c-5a47-47e6-8dd6-fa32a52559f6	Product name	1	20151109
29ae08d1-069f-9822-4820-152d5dc67797	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
63304-210-01	GLYCOPYRROLATE TABLETS, USP Rx only
63304-210-10	GLYCOPYRROLATE TABLETS, USP Rx only
63304-210-30	GLYCOPYRROLATE TABLETS, USP Rx only
63304-210-69	GLYCOPYRROLATE TABLETS, USP Rx only

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
63304-210-01	Glycopyrrolate	100 in 1 BOTTLE	TABLET	100	3
63304-210-10	Glycopyrrolate	1000 in 1 BOTTLE	TABLET	1000	3
63304-210-11	Glycopyrrolate	10 in 1 BLISTER PACK	TABLET	10	3
63304-210-30	Glycopyrrolate	30 in 1 BOTTLE	TABLET	30	3
63304-210-69	Glycopyrrolate	1 in 1 BOX	TABLET	1	3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
GLYCOPYRROLATE	ACTIVE INGREDIENT	V92SO9WP2I	GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.]	3
GLYCOPYRRONIUM	ACTIVE MOIETY	A14FB57V1D	GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.]	3
ANHYDROUS DIBASIC CALCIUM PHOSPHATE	INACTIVE INGREDIENT	L11K75P92J	GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.]	3
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.]	3
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.]	3
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.]	3
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.]	3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
63304-210	GLYCOPYRROLATE TABLET [RANBAXY PHARMACEUTICALS INC.]	3	Legacy NDC, 5 package rows	20130214_4ec4e4e4-ce23-463b-9296-bff35b005632.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V92SO9WP2I	GLYCOPYRROLATE	51186-83-5	GLYCOPYRROLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197738	glycopyrrolate 1 MG Oral Tablet	PSN	4ec4e4e4-ce23-463b-9296-bff35b005632	3
197739	glycopyrrolate 2 MG Oral Tablet	PSN	4ec4e4e4-ce23-463b-9296-bff35b005632	3
197738	glycopyrrolate 1 MG Oral Tablet	SCD	4ec4e4e4-ce23-463b-9296-bff35b005632	3
197739	glycopyrrolate 2 MG Oral Tablet	SCD	4ec4e4e4-ce23-463b-9296-bff35b005632	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Status
63304-210-01	63304021001	100 in 1 BOTTLE	Historical
63304-210-10	63304021010	1000 in 1 BOTTLE	Historical
63304-210-11	63304021011	10 in 1 BLISTER PACK	Historical
63304-210-30	63304021030	30 in 1 BOTTLE	Historical
63304-210-69	63304021069	1 in 1 BOX	Historical

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
GLYCOPYRROLATE TABLETS, USP Rx only	Ranbaxy Pharmaceuticals Inc. \| Ohm Laboratories Inc.	2013-01-03	HUMAN PRESCRIPTION DRUG LABEL	3